![Martin Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Evans
Oprichter bij
Celixir Plc
Vermogen: 2 M $ op 31-12-2025
Profiel
Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 18,92% | 21-04-2026 | 16.855.254 ( 18,92% ) | 2 M $ | 31-12-2025 |
| 03-12-2024 | 269 ( 0% ) | 35 $ | 31-07-2026 |
Actieve functies van Martin Evans
| Bedrijven | Functie | Begin |
|---|---|---|
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Oprichter | 28-12-2016 |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Oprichter | 01-05-2019 |
Eerdere bekende functies van Martin Evans
| Bedrijven | Functie | Einde |
|---|---|---|
| ROQT THER | Hoofd Techniek/Wetenschap/O&O | 23-05-2024 |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | President | - |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Oprichter | - |
Opleiding van Martin Evans
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Christ's College (United Kingdom)
 Christ's College (United Kingdom) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
